Medindia
About ▼ Careers Internship MedBlog Contact us
English (US) ▼
Medindia
LOGIN REGISTER
Advertisement

Jubilant Life Sciences Announces Appointment of Dr. Syed Kazmi as President and CEO of its New Innovative Biopharmaceutical Company in the U.S. - Jubilant Therapeutics Inc.

Monday, September 9, 2019 General News
Advertisement
Sponsored Post and Backlink Submission


Latest Press Release on General News

Introducing Haven of Hope: Memphis' New Eating Disorder and Trauma Treatment Facility
MEMPHIS, Tenn. , May 24, 2024 /PRNewswire/ -- Memphis is set to welcome Haven of Hope, a new facility dedicated to providing comprehensive eating disorder and trauma treatment ...
Theranica: 1 IN 4 ADOLESCENTS SUFFER FROM MIGRAINE DISEASE AND ARE AT RISK FOR LONG-TERM DISABILITY
Uncovering the hidden crisis and why treatments and insurance coverage are falling short. BRIDGEWATER, N.J. and NETANYA, Israel , May 23, 2024 /PRNewswire/ -- BACKGROUND...
Provenance Bio Announces Results for Recombinant Protein Demonstrating Cell Adhesion Functionality that Can Replace Animal-Derived Proteins
SAN DIEGO , May 22, 2024 /PRNewswire/ -- Provenance Bio, an alternative protein company, announced today that its hydroxylated type I collagen protein demonstrates proof of functi...
CEFALY Technology Launches the CEFALY Cares Program by Providing Migraine Relief to Domestic Violence Survivors
DARIEN, Conn. , May 21, 2024 /PRNewswire/ -- Medical device maker CEFALY Technology announced a new initiative, CEFALY Cares, which will assist and empower people living with migr...
Philips Foundation 2023 Annual Report: Unlocking Quality Medical Services for Over 28 Million People in Underserved Communities
May 21, 2024 Progress towards Philips Foundation’s 2030 target of 100 million lives improved in underserved communities each year 17 new initiatives with strategic partners and ...
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close